Equity research analysts and institutional valuation models determine the fair value of Kenvue (NYSE: KVUE) stock by evaluating its steady cash flow generation, defensive consumer brand portfolio, and projected long-term earnings growth. Consensus target estimates typically position its fair value above current trading prices, supported by consistent dividend payouts and stable defensive market demand across its core healthcare segments.